Keyphrases
Acute Lymphoblastic Leukemia
100%
Canada
9%
Cancer Development
9%
Clinical High Risk
9%
Conflict Data
9%
Cox Regression Model
9%
De Novo Acute Lymphoblastic Leukaemia
9%
Event-free Survival
45%
Exposure Parameters
9%
High Risk
9%
High-risk Acute Leukemia
9%
Leukemia
9%
Leukemia Diagnosis
9%
Low Risk
9%
Low-risk Patients
9%
Median Time
9%
Medical Intervention
9%
Multivariable Cox Regression
9%
Overall Survival
45%
Population-based Retrospective Cohort Study
9%
Precursor B-cell Acute Lymphoblastic Leukemia
9%
Second Malignancy
9%
Thromboembolism
100%
Thrombosis
100%
Tumor Thromboembolism
9%
Ultra-high Risk
27%
Young People
9%
Medicine and Dentistry
Acute B-Cell Lymphoblastic Leukemia
8%
Acute Lymphoblastic Leukemia
100%
Event Free Survival
41%
Leukemia
8%
Malignant Neoplasm
16%
Medical Intervention
8%
Overall Survival
41%
Precursor
8%
Proportional Hazards Model
8%
Retrospective Cohort Study
8%
Second Cancer
8%
Thromboembolism
100%
Thrombosis
100%
Biochemistry, Genetics and Molecular Biology
B Cell
20%
Cohort Study
20%
Event Free Survival
100%
Overall Survival
100%
Precursor
20%
Immunology and Microbiology
B Cell
20%
Event Free Survival
100%
Overall Survival
100%
Precursor
20%